Equity Analysis /

INTERMARKET INTEL: Pakistan pharma update – FY 18 drug price increase due, but not immediately

    Tellimer Research
    30 July 2018
    Published byTellimer Research
    As per news reports, pharmaceutical companies have reportedly raised prices for 10,000 medicines by up to 3.92% (FY 18 average CPI). However, as per our channel checks within listed companies, the discussion on price hikes is still ongoing and no major listed company (MNC or local) has undertaken such an increase for FY 18 so far.